UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Multiple mechanisms confer drug resistance to mitoxantrone in the human 8226 myeloma cell line

Cancer research (Chicago, Ill.), 1999-03, Vol.59 (5), p.1021-1028

1999

Volltextzugriff (PDF)

Lung Resistance-Related Protein: Determining Its Role in Multidrug Resistance

JNCI : Journal of the National Cancer Institute, 1999-10, Vol.91 (19), p.1604-1605

1999

Volltextzugriff (PDF)

P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil

Journal of clinical oncology, 1991-01, Vol.9 (1), p.17-24

1991

Volltextzugriff (PDF)

Inhibition of JAK Kinase Activity Enhances Fas-mediated Apoptosis but Reduces Cytotoxic Activity of Topoisomerase II Inhibitors in U266 Myeloma Cells

Clinical cancer research, 2001-12, Vol.7 (12), p.4262-4271

2001

Volltextzugriff (PDF)

Systemic Toxic Effects Associated With High-Dose Verapamil Infusion and Chemotherapy Administration

JNCI : Journal of the National Cancer Institute, 1991-01, Vol.83 (2), p.105-110

1991

Volltextzugriff (PDF)

Identification of cryptic sites of DNA sequence amplification in human breast cancer by chromosome microdissection

Nature genetics, 1994-10, Vol.8 (2), p.155-161

1994

Volltextzugriff (PDF)

Role of the tumor microenvironment in mediating de novo resistance to drugs and physiological mediators of cell death

Oncogene, 2003-10, Vol.22 (47), p.7396-7402

2003

Volltextzugriff (PDF)

Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells

Immunity (Cambridge, Mass.), 1999, Vol.10 (1), p.105-115

1999

Volltextzugriff (PDF)

A phase III randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma. A southwest oncology group study

Cancer, 1995-02, Vol.75 (3), p.815-820

1995

Volltextzugriff (PDF)

Flow cytometric assay of modulation of P-glycoprotein function in whole blood by the multidrug resistance inhibitor GG918

Clinical cancer research, 1996-01, Vol.2 (1), p.7-12

1996

Volltextzugriff (PDF)

Cell adhesion-mediated drug resistance (CAM-DR) is associated with activation of NF-κB (RelB/p50) in myeloma cells

Oncogene, 2003-04, Vol.22 (16), p.2417-2421

2003

Volltextzugriff (PDF)

Myeloma Cells Selected for Resistance to CD95-Mediated Apoptosis Are Not Cross-Resistant to Cytotoxic Drugs: Evidence for Independent Mechanisms of Caspase Activation

Blood, 1999-07, Vol.94 (1), p.265-274

1999

Volltextzugriff (PDF)

Analysis of multidrug resistance-associated protein (MRP) messenger RNA in normal and malignant hematopoietic cells

Cancer research (Chicago, Ill.), 1994-09, Vol.54 (17), p.4676-4679

1994

Volltextzugriff (PDF)

P-Glycoprotein Expression in Human Plasma Cell Myeloma: Correlation With Prior Chemotherapy

Blood, 1993-01, Vol.81 (2), p.490-495

1993

Volltextzugriff (PDF)

Detection of multidrug resistance gene expression in multiple myeloma

Leukemia, 1997-07, Vol.11 (7), p.1166-1169

Dalton, W S

1997

Volltextzugriff (PDF)

Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line

British journal of cancer, 1991-06, Vol.63 (6), p.923-929

1991

Volltextzugriff (PDF)

Clonal variability in CD95 expression is the major determinant in fas-mediated, but not chemotherapy-mediated apoptosis in the RPMI 8226 multiple myeloma cell line

Leukemia, 2000-05, Vol.14 (5), p.830-840

2000

Volltextzugriff (PDF)

Multidrug-Resistant Myeloma: Laboratory and Clinical Effects of Verapamil as a Chemosensitizer

Blood, 1991-07, Vol.78 (1), p.44-50

1991

Volltextzugriff (PDF)

Immunohistochemical Detection and Quantitation of P-Glycoprotein in Multiple Drug-Resistant Human Myeloma Cells: Association With Level of Drug Resistance and Drug Accumulation

Blood, 1989-02, Vol.73 (3), p.747-752

1989

Volltextzugriff (PDF)

The tumor microenvironment: focus on myeloma

Cancer treatment reviews, 2003-05, Vol.29, p.11-19

Dalton, William S

2003

Volltextzugriff (PDF)

Cytokine-Based Tumor Cell Vaccine Is Equally Effective Against Parental and Isogenic Multidrug-Resistant Myeloma Cells: The Role of Cytotoxic T Lymphocytes

Blood, 1999-03, Vol.93 (6), p.1831-1837

1999

Volltextzugriff (PDF)

Prediction of Doxorubicin Resistance In Vitro in Myeloma, Lymphoma, and Breast Cancer by P-Glycoprotein Staining

JNCI : Journal of the National Cancer Institute, 1989-05, Vol.81 (9), p.696-701

1989

Volltextzugriff (PDF)

Cell Adhesion Is a Key Determinant in de Novo Multidrug Resistance (MDR): New Targets for the Prevention of Acquired MDR

Molecular cancer therapeutics, 2001-11, Vol.1 (1), p.69-78

2001

Volltextzugriff (PDF)

Dysregulation of CD95/CD95 Ligand-Apoptotic Pathway in CD3+ Large Granular Lymphocyte Leukemia

Blood, 1998-12, Vol.92 (12), p.4771-4777

1998

Volltextzugriff (PDF)

Cytokeratin expression results in a drug-resistant phenotype to six different chemotherapeutic agents

Clinical cancer research, 1996-01, Vol.2 (1), p.97-105

1996

Volltextzugriff (PDF)

26 – 50 von 4.129

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.421)
Mit Volltextzugriff
(3.202)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(1.835)
Ingenta
(1.587)
Free E-Journal (出版社公開部分のみ）
(1.477)
Journals@Ovid Full Text
(1.282)
Publisher or Other Site
(1.032)
Elsevier ScienceDirect Journals Collection
(696)
IngentaConnect Journals
(636)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(526)
Wiley Backfiles (~2019)
(430)
Wiley Online Library Full Collection 2018
(259)
JSTOR
(243)
Oxford Journals
(217)
2022 ECC(Springer)
(212)
Business Source Ultimate
(170)
SAGE Journals
(143)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(138)
IEEE Xplore
(136)
Nature International Weekly Journal of Science
(134)
Nexis Uni
(130)
Taylor & Francis
(124)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Multiple mechanisms confer drug resistance to mitoxantrone in the human 8226 myeloma cell line

Lung Resistance-Related Protein: Determining Its Role in Multidrug Resistance

P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil

Inhibition of JAK Kinase Activity Enhances Fas-mediated Apoptosis but Reduces Cytotoxic Activity of Topoisomerase II Inhibitors in U266 Myeloma Cells

Systemic Toxic Effects Associated With High-Dose Verapamil Infusion and Chemotherapy Administration

Identification of cryptic sites of DNA sequence amplification in human breast cancer by chromosome microdissection

Role of the tumor microenvironment in mediating de novo resistance to drugs and physiological mediators of cell death

Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells

A phase III randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma. A southwest oncology group study

Flow cytometric assay of modulation of P-glycoprotein function in whole blood by the multidrug resistance inhibitor GG918

Cell adhesion-mediated drug resistance (CAM-DR) is associated with activation of NF-κB (RelB/p50) in myeloma cells

Myeloma Cells Selected for Resistance to CD95-Mediated Apoptosis Are Not Cross-Resistant to Cytotoxic Drugs: Evidence for Independent Mechanisms of Caspase Activation

Analysis of multidrug resistance-associated protein (MRP) messenger RNA in normal and malignant hematopoietic cells

P-Glycoprotein Expression in Human Plasma Cell Myeloma: Correlation With Prior Chemotherapy

Detection of multidrug resistance gene expression in multiple myeloma

Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line

Clonal variability in CD95 expression is the major determinant in fas-mediated, but not chemotherapy-mediated apoptosis in the RPMI 8226 multiple myeloma cell line

Multidrug-Resistant Myeloma: Laboratory and Clinical Effects of Verapamil as a Chemosensitizer

Immunohistochemical Detection and Quantitation of P-Glycoprotein in Multiple Drug-Resistant Human Myeloma Cells: Association With Level of Drug Resistance and Drug Accumulation

The tumor microenvironment: focus on myeloma

Cytokine-Based Tumor Cell Vaccine Is Equally Effective Against Parental and Isogenic Multidrug-Resistant Myeloma Cells: The Role of Cytotoxic T Lymphocytes

Prediction of Doxorubicin Resistance In Vitro in Myeloma, Lymphoma, and Breast Cancer by P-Glycoprotein Staining

Cell Adhesion Is a Key Determinant in de Novo Multidrug Resistance (MDR): New Targets for the Prevention of Acquired MDR

Dysregulation of CD95/CD95 Ligand-Apoptotic Pathway in CD3+ Large Granular Lymphocyte Leukemia

Cytokeratin expression results in a drug-resistant phenotype to six different chemotherapeutic agents

Suchergebnisse filtern